BlackRock
LUNG icon

BlackRock’s Pulmonx LUNG Stock Holding History

BlackRock’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.15M Sell
882,490
-1,779,117
-67% -$2.45M ﹤0.01% 4318
2026
Q1 		$3.43M Sell
2,661,607
-44,583
-2% -$73.7K ﹤0.01% 3973
2025
Q4 		$5.98M Buy
2,706,190
+31,369
+1% +$59K ﹤0.01% 3761
2025
Q3 		$4.33M Sell
2,674,821
-15,977
-0.6% -$33.4K ﹤0.01% 3839
2025
Q2 		$6.97M Sell
2,690,798
-96,598
-3% -$381K ﹤0.01% 3598
2025
Q1 		$18.8M Sell
2,787,396
-62,758
-2% -$444K ﹤0.01% 2982
2024
Q4 		$19.4M Buy
2,850,154
+54,593
+2% +$359K ﹤0.01% 3072
2024
Q3 		$23.2M Buy
2,795,561
+127,795
+5% +$925K ﹤0.01% 2939
2024
Q2 		$16.9M Sell
2,667,766
-369,500
-12% -$2.84M ﹤0.01% 3078
2024
Q1 		$28.2M Sell
3,037,266
-79,797
-3% -$936K ﹤0.01% 2794
2023
Q4 		$39.7M Buy
3,117,063
+181,403
+6% +$1.89M ﹤0.01% 2623
2023
Q3 		$30.3M Buy
2,935,660
+23,894
+0.8% +$277K ﹤0.01% 2700
2023
Q2 		$38.2M Buy
2,911,766
+205,821
+8% +$2.52M ﹤0.01% 2653
2023
Q1 		$30.3M Buy
2,705,945
+12,305
+0.5% +$121K ﹤0.01% 2753
2022
Q4 		$22.7M Buy
2,693,640
+225,355
+9% +$2.14M ﹤0.01% 2962
2022
Q3 		$41.1M Buy
2,468,285
+37,968
+2% +$699K ﹤0.01% 2592
2022
Q2 		$35.8M Sell
2,430,317
-329,738
-12% -$6.79M ﹤0.01% 2721
2022
Q1 		$68.5M Buy
2,760,055
+41,724
+2% +$1.08M ﹤0.01% 2380
2021
Q4 		$87.2M Sell
2,718,331
-19,488
-0.7% -$712K ﹤0.01% 2296
2021
Q3 		$98.5M Buy
2,737,819
+414,180
+18% +$16.3M ﹤0.01% 2227
2021
Q2 		$103M Buy
2,323,639
+1,406,718
+153% +$61.3M ﹤0.01% 2229
2021
Q1 		$41.9M Buy
916,921
+66,313
+8% +$3.8M ﹤0.01% 2734
2020
Q4 		$58.7M Buy
+850,608
New +$41.7M ﹤0.01% 2379

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ECM
ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

BlackRock's LUNG Position: Q2 2026 in Review

BlackRock reduced its Pulmonx (LUNG) stake by 67% in Q2 2026, selling an estimated $2.45M and leaving 882,490 shares worth $1.15M. The position accounts for ﹤0.01% of the portfolio, ranked #4318.

BlackRock first reported a position in LUNG in Q4 2020 and has held it in 23 quarters since. The position peaked at $103M in Q2 2021. 107 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.

  • BlackRock held 882,490 shares of Pulmonx worth $1.15M as of Q2 2026.
  • BlackRock sold 1,779,117 Pulmonx shares in Q2 2026, an estimated $2.45M.
  • Pulmonx made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #4318 holding.
  • BlackRock first reported a position in Pulmonx in Q4 2020 and has held it in 23 quarters since.
  • BlackRock's Pulmonx position peaked at $103M in Q2 2021.
  • 107 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.